Gaucher Disease Registry – Global Data Collection and Sharing of the Variability, Progression and Natural History of Gaucher Disease

Summary

An ongoing registry of disease outcomes for patients with Gaucher disease.
The Registry is an international multi-center, strictly observational program for patients with Gaucher Disease; no experimental intervention is involved. Thus, a patient will undergo clinical assessments and receive care as determined by the patient’s physician.

The goal of the Gaucher Registry is to collect clinical data on people with Gaucher disease around the world in an effort to help healthcare professionals involved in the treatment or diagnosis of Gaucher disease better understand it and its management.

The Registry database has been designed to collect a variety of baseline and follow-up data obtained through routine clinical and laboratory assessments. All data submission is voluntary and there are no predetermined follow-up periods. Participating sites are encouraged to enter comprehensive baseline data at enrollment and to perform follow-up assessments at regular intervals. While the protocol provides recommended schedules of Assessments each physician is solely responsible for determining the appropriate clinical care for each patient.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 0 to 100

Inclusion criteria:

Patients with confirmed diagnosis of Gaucher disease and are willing and able to provide informed consent.

Exclusion criteria:

There are no exclusion criteria for this study.

Participate

This study is not currently accepting expressions of interest via the website. Please see contact information below.

Additional information

Contact information

By referral only to Dr Aneal Khan at the Metabolics & Genetics Clinic at Alberta Children's Hospital

Principal investigator:

Aneal Khan

Clinical trial:

No

REB-ID:

HREBA.CHC-22-0022